0001140361-21-010380.txt : 20210329 0001140361-21-010380.hdr.sgml : 20210329 20210329070034 ACCESSION NUMBER: 0001140361-21-010380 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210325 FILED AS OF DATE: 20210329 DATE AS OF CHANGE: 20210329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chambers Rebecca CENTRAL INDEX KEY: 0001823563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39513 FILM NUMBER: 21779431 MAIL ADDRESS: STREET 1: 3052 ORCHARD DR. CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outset Medical, Inc. CENTRAL INDEX KEY: 0001484612 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 200514392 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 669-231-8200 MAIL ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: Home Dialysis Plus, Ltd. DATE OF NAME CHANGE: 20100219 4 1 form4.xml FORM 4 X0306 4 2021-03-25 0001484612 Outset Medical, Inc. OM 0001823563 Chambers Rebecca 3052 ORCHARD DRIVE SAN JOSE CA 95134 true Chief Financial Officer Common Stock 2021-03-25 4 M 0 16727 6.25 A 30324 D Common Stock 2021-03-25 4 S 0 3592 49.1133 D 26732 D Common Stock 2021-03-25 4 S 0 13135 50.1639 D 13597 D Stock Option (Right to Buy) 6.25 2021-03-25 4 M 0 16727 0 D 2029-09-10 Common Stock 16727 127926 D This option vests 25% on June 3, 2020, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.62 to $49.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $49.68 to $51.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. This Form 4 corrects the exercise price previously reported as $6.24 on the Form 3 filed on September 14, 2020. /s/ Rebecca Chambers 2021-03-26